MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MEIP MEI Pharma

休市中 09-10 16:00:00 EDT

3.07

+0.00

0.00%

最高3.07	最低3.07	成交量0.00
今开3.07	昨收3.07	日振幅0.00%
总市值1.01亿	流通市值9,719万	总股本3,284万
成交额1,212万	换手率0.00%	流通股本3,166万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MEIP","market":"US","secType":"STK","nameCN":"MEI Pharma","latestPrice":3.07,"timestamp":1757534400000,"preClose":3.07,"halted":8,"volume":0,"delay":0,"floatShares":31657199,"shares":32837700,"eps":-4.752063,"marketStatus":"休市中","change":0,"latestTime":"09-10 16:00:00 EDT","open":3.07,"high":3.07,"low":3.07,"amount":12121549.559700001,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.752063,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"symbolChange":{"newSymbol":"LITS","executeDate":"2025-09-11"},"adr":0,"adrRate":0,"listingDate":1071723600000,"exchange":"NASDAQ","adjPreClose":3.07,"volumeRatio":0},"requestUrl":"/m/hq/s/MEIP","defaultTab":"news","newsList":[{"id":"1133041017","title":"MEI Pharma公司纳斯达克股票代码将于2025年9月11日开盘时变更","url":"https://stock-news.laohu8.com/highlight/detail?id=1133041017","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133041017?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:03","pubTimestamp":1757509401,"startTime":"0","endTime":"0","summary":"MEI Pharma公司宣布，其在纳斯达克的股票交易代码将于2025年9月11日市场开盘时正式变更生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITS","MEIP","BK4139"],"gpt_icon":0},{"id":"2558659936","title":"Mei Pharma, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558659936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558659936?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:32","pubTimestamp":1754919142,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时32分，Mei Pharma, Inc.股票出现波动，股价急速拉升5.01%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Lenz Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为1765.37%、214.48%、76.61%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为33.16%、32.31%、11.88%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121322294dcbf0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121322294dcbf0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2558579651","title":"Mei Pharma, Inc.盘中异动 大幅拉升5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558579651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558579651?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:36","pubTimestamp":1754674587,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时36分，Mei Pharma, Inc.股票出现波动，股价急速拉升5.29%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809013627a6db71b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809013627a6db71b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2557567130","title":"Mei Pharma, Inc.盘中异动 早盘快速拉升5.82%报5.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557567130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557567130?lang=zh_cn&edition=full","pubTime":"2025-08-07 23:11","pubTimestamp":1754579509,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日23时11分，Mei Pharma, Inc.股票出现波动，股价急速拉升5.82%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080723114994d5c879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080723114994d5c879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2556382447","title":"Mei Pharma, Inc.盘中异动 股价大涨6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556382447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556382447?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314376,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，Mei Pharma, Inc.股票出现波动，股价快速拉升6.57%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Soligenix, Inc.涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2301.36%、825.00%、395.03%，振幅较大的相关个股有Psyence Biomedical Ltd.、Soligenix, Inc.、凯信远达，振幅分别为28.60%、19.53%、15.35%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213256a474901e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213256a474901e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2556633847","title":"Mei Pharma, Inc.8月1日成交额为169.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556633847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556633847?lang=zh_cn&edition=full","pubTime":"2025-08-02 11:56","pubTimestamp":1754106971,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Mei Pharma, Inc.成交额为169.38万美元，成交额较昨日增加20.78%，当日成交量为34.95万股。Mei Pharma, Inc.于2025年8月1日跌5.44%，报4.87美元，该股过去5个交易日跌27.74%，年初至今涨97.97%，过去60日涨129.72%。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115617a470c613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115617a470c613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2556986630","title":"Mei Pharma, Inc.7月31日成交额为140.24万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556986630","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556986630?lang=zh_cn&edition=full","pubTime":"2025-08-01 11:51","pubTimestamp":1754020282,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Mei Pharma, Inc.成交额为140.24万美元，成交额较昨日减少46.74%，当日成交量为27.27万股。Mei Pharma, Inc.于2025年7月31日涨1.98%，报5.15美元，该股过去5个交易日跌21.97%，年初至今涨109.35%，过去60日涨150.0%。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801115126a46ed715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801115126a46ed715&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2555091171","title":"Mei Pharma, Inc.7月29日成交额为573.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555091171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555091171?lang=zh_cn&edition=full","pubTime":"2025-07-30 11:57","pubTimestamp":1753847834,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Mei Pharma, Inc.成交额为573.38万美元，成交额较昨日减少18.02%，当日成交量为109.16万股。Mei Pharma, Inc.于2025年7月29日跌15.13%，报5.05美元，该股过去5个交易日跌26.38%，年初至今涨105.28%，过去60日涨146.34%。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730115722a6c8ed1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730115722a6c8ed1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2555081067","title":"Mei Pharma, Inc.7月28日成交额为699.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555081067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555081067?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:55","pubTimestamp":1753761309,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Mei Pharma, Inc.成交额为699.44万美元，成交额较昨日增加83.36%，当日成交量为111.98万股。Mei Pharma, Inc.于2025年7月28日跌11.72%，报5.95美元，该股过去5个交易日跌9.16%，年初至今涨141.87%，过去60日涨191.67%。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729115510a6c709cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729115510a6c709cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2554777270","title":"Mei Pharma, Inc.盘中异动 急速下挫5.03%报6.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777270?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:13","pubTimestamp":1753712028,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时13分，Mei Pharma, Inc.股票出现波动，股价急速跳水5.03%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为296.28%、155.84%、105.64%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为102.74%、58.39%、50.07%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822134894bf7eaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822134894bf7eaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2553295688","title":"Mei Pharma, Inc.7月22日成交额为1314.20万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553295688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553295688?lang=zh_cn&edition=full","pubTime":"2025-07-23 11:43","pubTimestamp":1753242230,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Mei Pharma, Inc.成交额为1314.20万美元，成交额较昨日减少78.49%，当日成交量为193.91万股。Mei Pharma, Inc.于2025年7月22日涨4.73%，报6.86美元，该股过去5个交易日涨123.45%，年初至今涨178.86%，过去60日涨217.59%。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723114353a6bc5278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723114353a6bc5278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2553408286","title":"Mei Pharma, Inc.7月21日成交额为6109.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553408286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553408286?lang=zh_cn&edition=full","pubTime":"2025-07-22 11:41","pubTimestamp":1753155691,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，Mei Pharma, Inc.成交额为6109.19万美元，成交额较昨日减少77.19%，当日成交量为835.57万股。Mei Pharma, Inc.于2025年7月21日涨10.64%，报6.55美元，该股过去5个交易日涨122.79%，年初至今涨166.26%，过去60日涨230.81%。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722114139a6b9ab31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722114139a6b9ab31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2551876961","title":"Mei Pharma, Inc.盘中异动 急速上涨6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551876961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551876961?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:57","pubTimestamp":1752505069,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时57分，Mei Pharma, Inc.股票出现异动，股价急速拉升6.51%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1942.94%、946.04%、588.18%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为210.04%、162.23%、125.73%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714225749a6a91397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714225749a6a91397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2550650288","title":"Mei Pharma, Inc.盘中异动 下午盘快速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650288?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:07","pubTimestamp":1752088069,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时07分，Mei Pharma, Inc.股票出现异动，股价急速拉升5.38%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710030749953c79fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710030749953c79fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2548867008","title":"Mei Pharma, Inc.盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548867008?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:45","pubTimestamp":1751388304,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时45分，Mei Pharma, Inc.股票出现波动，股价大幅上涨5.06%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702004504979621e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702004504979621e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2547138540","title":"Mei Pharma, Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547138540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547138540?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:50","pubTimestamp":1751295027,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时50分，Mei Pharma, Inc.股票出现异动，股价大幅拉升5.36%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Vor Biopharma Inc.涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为3645.54%、297.77%、98.79%，振幅较大的相关个股有Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为117.82%、56.94%、50.00%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302250289794b878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302250289794b878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2542344938","title":"Mei Pharma, Inc.盘中异动 下午盘股价大涨5.43%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542344938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542344938?lang=zh_cn&edition=full","pubTime":"2025-06-11 02:17","pubTimestamp":1749579429,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日02时17分，Mei Pharma, Inc.股票出现异动，股价大幅上涨5.43%。截至发稿，该股报2.33美元/股，成交量6809股，换手率0.10%，振幅7.18%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611021710a4a249e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611021710a4a249e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2540950957","title":"Mei Pharma, Inc.盘中异动 急速跳水6.24%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540950957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540950957?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:39","pubTimestamp":1748871575,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时39分，Mei Pharma, Inc.股票出现异动，股价大幅跳水6.24%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213936976e8257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213936976e8257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2539835273","title":"Mei Pharma, Inc.盘中异动 早盘大幅下跌5.25%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539835273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539835273?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:58","pubTimestamp":1748613532,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时58分，Mei Pharma, Inc.股票出现波动，股价急速下挫5.25%。截至发稿，该股报2.08美元/股，成交量118股，换手率0.00%，振幅0.00%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为3.75%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530215853a492f65d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530215853a492f65d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2537644488","title":"Mei Pharma, Inc.盘中异动 大幅上涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537644488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537644488?lang=zh_cn&edition=full","pubTime":"2025-05-21 00:09","pubTimestamp":1747757395,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日00时09分，Mei Pharma, Inc.股票出现波动，股价快速拉升5.77%。Mei Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃，换手率分别为4287.88%、1552.03%、1081.53%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为174.55%、100.00%、95.65%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521000956aa2c944d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521000956aa2c944d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXS","MEIP","BK4139","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.meipharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.2742},{"period":"6month","weight":0.4077},{"period":"1year","weight":0.137},{"period":"ytd","weight":0.248}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MEI Pharma, Inc.是一家临床阶段的制药公司，致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道，并通过临床开发、战略合作伙伴关系以及外包许可或商业化（视情况而定）在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.061622},{"month":2,"riseRate":0.409091,"avgChangeRate":-0.005853},{"month":3,"riseRate":0.409091,"avgChangeRate":-0.074385},{"month":4,"riseRate":0.545455,"avgChangeRate":0.020025},{"month":5,"riseRate":0.454545,"avgChangeRate":0.039254},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.082941},{"month":7,"riseRate":0.363636,"avgChangeRate":0.076909},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.010903},{"month":9,"riseRate":0.52381,"avgChangeRate":0.055963},{"month":10,"riseRate":0.4,"avgChangeRate":-0.06033},{"month":11,"riseRate":0.45,"avgChangeRate":-0.037118},{"month":12,"riseRate":0.238095,"avgChangeRate":0.017657}],"exchange":"NASDAQ","name":"MEI Pharma","nameEN":"MEI Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MEI Pharma,MEIP,MEI Pharma股票,MEI Pharma股票老虎,MEI Pharma股票老虎国际,MEI Pharma行情,MEI Pharma股票行情,MEI Pharma股价,MEI Pharma股市,MEI Pharma股票价格,MEI Pharma股票交易,MEI Pharma股票购买,MEI Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}